UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$425M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$375M |
| 3 |
CRH
CRH
|
$264M |
| 4 |
Advanced Micro Devices
AMD
|
$216M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$205M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$523M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
$455M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$382M |
| 4 |
Microsoft
MSFT
|
$350M |
| 5 |
UnitedHealth
UNH
|
$320M |
Sector Composition
| 1 | Technology | 16.51% |
| 2 | Financials | 8.9% |
| 3 | Healthcare | 8.35% |
| 4 | Consumer Discretionary | 6.66% |
| 5 | Industrials | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Norfolk Southern
NSC
$61.9B
| $135M | 0.05% |
684,372
-26,667
| -4% | -$5.25M |
|
302
International Flavors & Fragrances
IFF
$16.8B
| $135M | 0.05% |
1,976,341
+178,376
| +10% | +$12.2M |
|
303
3M
MMM
$81.9B
| $135M | 0.05% |
1,438,793
-286,385
| -17% | -$26.8M |
|
304
Crown Castle
CCI
$43.1B
| $134M | 0.05% |
1,461,052
-15,209
| -1% | -$1.4M |
|
305
CrowdStrike
CRWD
$103B
| $133M | 0.05% |
794,483
-159,441
| -17% | -$26.7M |
|
306
VanEck Oil Services ETF
OIH
$874M
| $133M | 0.05% |
384,517
+272,266
| +243% | +$93.9M |
|
307
AstraZeneca
AZN
$247B
| $133M | 0.05% |
1,957,267
+171,480
| +10% | +$11.6M |
|
308
Vanguard FTSE Europe ETF
VGK
$26.4B
| $131M | 0.05% |
2,253,332
-815,132
| -27% | -$47.2M |
|
309
Ecolab
ECL
$78.2B
| $131M | 0.05% |
770,372
+18,923
| +3% | +$3.21M |
|
310
Vanguard S&P 500 Growth ETF
VOOG
$18.8B
| $130M | 0.04% |
526,638
+3,807
| +0.7% | +$940K |
|
311
iShares Core S&P US Growth ETF
IUSG
$24B
| $128M | 0.04% |
1,351,043
-131,185
| -9% | -$12.4M |
|
312
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.1B
| $128M | 0.04% |
2,626,560
+304,117
| +13% | +$14.8M |
|
313
Vanguard Intermediate-Term Bond ETF
BIV
$23.9B
| $128M | 0.04% |
1,764,907
+314,952
| +22% | +$22.8M |
|
|
BSCO
314
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $126M | 0.04% |
6,109,275
-738,911
| -11% | -$15.3M |
|
315
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.2B
| $126M | 0.04% |
1,980,267
+156,040
| +9% | +$9.91M |
|
316
SPDR S&P Biotech ETF
XBI
$5.21B
| $126M | 0.04% |
1,719,934
+433,408
| +34% | +$31.6M |
|
317
Fiserv
FI
$73.1B
| $124M | 0.04% |
1,101,986
-203,856
| -16% | -$23M |
|
318
Freeport-McMoran
FCX
$63.8B
| $124M | 0.04% |
3,337,694
+216,660
| +7% | +$8.08M |
|
319
Nasdaq
NDAQ
$53.5B
| $123M | 0.04% |
2,540,810
-244,484
| -9% | -$11.9M |
|
320
lululemon athletica
LULU
$23.6B
| $123M | 0.04% |
318,227
+113,252
| +55% | +$43.7M |
|
321
Vertex Pharmaceuticals
VRTX
$101B
| $123M | 0.04% |
352,698
-131,183
| -27% | -$45.6M |
|
322
iShares Core S&P Total US Stock Market ETF
ITOT
$74.1B
| $122M | 0.04% |
1,299,226
-15,174
| -1% | -$1.43M |
|
323
Alerian MLP ETF
AMLP
$10.6B
| $122M | 0.04% |
2,884,519
+129,611
| +5% | +$5.47M |
|
324
General Dynamics
GD
$87.1B
| $122M | 0.04% |
550,247
-115,750
| -17% | -$25.6M |
|
325
iShares S&P 100 ETF
OEF
$21.7B
| $121M | 0.04% |
605,486
-30,156
| -5% | -$6.05M |
|